Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment

Vega-Garcia, N; Perez-Jaume, S; Esperanza-Cebollada, E; Vicente-Garces, C; Torrebadell, M; Jimenez-Velasco, A; Ortega, M; Llop, M; Abad, L; Vagace, JM; Minguela, A; Pratcorona, M; Sanchez-Garcia, J; Garcia-Calderon, CB; Gomez-Casares, MT; Martin-Clavero, E; Escudero, A; Martinez-Gallo, MR; Munoz, L; Velasco, MR; Garcia-Morin, M; Catala, A; Pascual, A; Velasco, P; Fernandez, JM; Lassaletta, A; Fuster, JL; Badell, I; Molinos-Quintana, A; Molines, A; Guerra-Garcia, P; Perez-Martinez, A; Garcia-Abos, M; Ortiz, RR; Pisa, S; Adan, R; de Heredia, CD; Dapena, JL; Rives, S; Ramirez-Orellana, M; Camos, M – 2021